We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Medulloblastoma and Dizziness—Reply

James Battiste, MD, PhD1; Francy Shu, MD2; Steven Vernino, MD, PhD2
[+] Author Affiliations
1Peggy and Charles Stephenson Cancer Center, University of Oklahoma, Oklahoma City
2Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas
JAMA Neurol. 2014;71(6):801-802. doi:10.1001/jamaneurol.2014.522.
Text Size: A A A
Published online


In Reply We completely agree that the standard initial step of treatment of adult medulloblastoma is maximal safe resection as outlined in the National Comprehensive Cancer Network guidelines. However, in the event that this resection is not possible, radiotherapy and postradiation chemotherapy are recommended. The professional opinion of the neurosurgeons treating the patient presented in the article1 was that surgical resection for the ill-defined lesion would be difficult and could result in neurologic sequelae that would be unacceptable for the patient. After that decision was made, the clinical course of action was radiotherapy followed by chemotherapy and close follow-up. We were not involved in the clinical decision making for this patient’s case. About 2 years after diagnosis, serial monitoring by magnetic resonance imaging discovered a more discrete enhancing nodule near the initial biopsy site. This nodule was completely resected and the patient is doing well.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





June 1, 2014
Miguel Gelabert-González, MD, PhD; Eduardo Arán-Echabe, MD
1Department of Surgery, University of Santiago de Compostela, Santiago de Compostela, Spain
JAMA Neurol. 2014;71(6):801. doi:10.1001/jamaneurol.2014.173.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...